Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 93.00
-2.25 (-2.36%)
Apr 28, 2026, 4:11 PM AEST
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 31, 2025, with 6.25% growth. This brings the company's revenue in the last twelve months to 2.34B, up 1.28% year-over-year. In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B with 4.81% growth.
Revenue (ttm)
2.34B
Revenue Growth
+1.28%
P/S Ratio
2.60
Revenue / Employee
425.18K
Employees
5,500
Market Cap
6.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 139.49M |
| SomnoMed | 118.50M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 58.49M |
| Lumos Diagnostics Holdings | 18.31M |
| 4DMedical | 5.81M |
| EMVision Medical Devices | 5.43M |
| Anteris Technologies Global | 2.87M |
Cochlear News
- 6 days ago - Cochlear Shares Plunge 39% After Profit Guidance Cut - GuruFocus
- 6 days ago - Cochlear (COH) Faces Major Stock Drop Amid Weak Market Conditions - GuruFocus
- 6 days ago - Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact - Reuters
- 6 days ago - 5 Reasons Cochlear Share Price Crashed 39% Today: Earnings Miss and Guidance Cut Shock Investors - International Business Times (Australia)
- 6 days ago - Cochlear Share Price Crashes 39% to $101.60 After Dismal HY26 Results and Guidance Cut - International Business Times (Australia)
- 6 days ago - Cochlear Lowers FY26 Underlying Net Profit Guidance - Nasdaq
- 6 days ago - Bang, crash, wallop: Cochlear tanks on ‘staggering’ bad news - The Australian Financial Review
- 6 days ago - Cochlear dives to 10-year low on profit downgrade - The Australian Financial Review